Carnosic acid protects against 6-hydroxydopamine-induced neurotoxicity in in vivo and in vitro model of Parkinson's disease: Involvement of antioxidative enzymes induction

被引:86
|
作者
Wu, Chi-Rei [1 ]
Tsai, Chia-Wen [2 ]
Chang, Shu-Wei [3 ]
Lin, Chia-Yuan [2 ]
Huang, Li-Chun [2 ]
Tsai, Chia-Wen [2 ]
机构
[1] China Med Univ, Coll Pharm, Sch Chinese Pharmaceut Sci & Chinese Med Resource, Taichung, Taiwan
[2] China Med Univ, Dept Nutr, Taichung, Taiwan
[3] Dayeh Univ, Dept Med Bot & Hlth Care, Changhua, Taiwan
关键词
Carnosic acid; Neuroprotection; Antioxidative enzymes; Apoptosis; Wistar rats; GLUTATHIONE METABOLISM; PC12; CELLS; OXIDATIVE STRESS; SH-SY5Y CELLS; APOPTOSIS; 6-OHDA; ACTIVATION; DEATH; CONSTITUENTS; BCL-2/BAX;
D O I
10.1016/j.cbi.2014.11.011
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The neuroprotective effects of carnosic acid (CA), a phenolic diterpene isolated from rosemary (Rosmarinus officinalis), have been widely investigated in recent years, however, its protection in in vivo still unclear. In this study, we investigated the behavioral activity and neuroprotective effects of CA in a rat model of Parkinson's disease (PD) induced by 6-hydroxydopamine (6-OHDA). Rats were treated with 20 mg/kg body weight of CA for 3 weeks before 6-OHDA exposure. Results indicated that CA improved the locomotor activity and reduced the apomorphine-caused rotation in 6-OHDA-stimulated rats. Significant protection against lipid peroxidation and GSH reduction was observed in the 6-OHDA rats pre-treated with CA. Pretreatment with CA increased the protein expression of gamma-glutamate-cysteine ligase catalytic subunit, gamma-glutamate-cysteine ligase modifier subunit, superoxide dismutase, and glutathione reductase compared with 6-OHDA-stimulated rats and SH-SY5Y cells. Immunoblots showed that the reduction of the Bcl-2/Bax ratio, the induction of caspase 3 cleavage, and the induction of poly(ADPribose) polymerase (PARP) cleavage by 6-OHDA was reversed in the presence of SB203580 (a p38 inhibitor) or SP600125 (a JNK inhibitor) in SH-SY5Y cells. Rats treated with CA reversed the 6-OHDA-mediated the activation of c-JunNH2-terminal kinase and p38, the down-regulation of the Bcl-2/Bax ratio, the up-regulation of cleaved caspase 3/caspase 3 and cleaved PARP/PARP ratio, and the down-regulation of tyrosine hydroxylase protein. However, BAM7, an activator of Bax, attenuated the effect of CA on apoptosis in SH-SY5Y cells. These results suggest that CA protected against 6-OHDA-induced neurotoxicity is attributable to its anti-apoptotic and anti-oxidative action. The present findings may help to clarify the possible mechanisms of rosemary in the neuroprotection of PD. (C) 2014 Published by Elsevier Ireland Ltd.
引用
收藏
页码:40 / 46
页数:7
相关论文
共 50 条
  • [41] Lipid profiles in the cerebrospinal fluid of rats with 6-hydroxydopamine-induced lesions as a model of Parkinson's disease
    Qiu, Jiewen
    Peng, Guoyou
    Tang, Yuting
    Li, Shiyin
    Liu, Zengfu
    Zheng, Jiayun
    Wang, Yunxin
    Liu, Hanqun
    Wei, Lijian
    Su, Yilin
    Lin, Yuwan
    Dai, Wei
    Zhang, Zhiling
    Chen, Xiang
    Ding, Liuyan
    Guo, Wenyuan
    Zhu, Xiaoqin
    Xu, Pingyi
    Mo, Mingshu
    FRONTIERS IN AGING NEUROSCIENCE, 2023, 14
  • [42] MPTP and 6-hydroxydopamine-induced neurodegeneration as models for Parkinson’s disease: neuroprotective strategies
    E. Grünblatt
    S. Mandel
    M. B. H. Youdim
    Journal of Neurology, 2000, 247 (Suppl 2) : II95 - II102
  • [43] Neuroprotective effect of hydroxysafflor yellow A on 6-hydroxydopamine-induced Parkinson's disease in rats
    Han, Bing
    Hu, Jia
    Shen, Jingyu
    Gao, Yonglin
    Lu, Yan
    Wang, Tian
    EUROPEAN JOURNAL OF PHARMACOLOGY, 2013, 714 (1-3) : 83 - 88
  • [44] Norharman exacerbates 6-hydroxydopamine-induced Parkinson's disease but cannot establish it alone
    Haghdoost-Yazdi, Hashem
    Movahedi, Mohadeseh
    Faraji, Ayda
    Sophiabadi, Mohamad
    PHYSIOLOGY AND PHARMACOLOGY, 2011, 15 (02): : 260 - 267
  • [45] MPTP and 6-hydroxydopamine-induced neurodegeneration as models for Parkinson's disease:: neuroprotective strategies
    Grünblatt, E
    Mandel, S
    Youdim, MBH
    JOURNAL OF NEUROLOGY, 2000, 247 : 95 - 102
  • [46] Ethyl pyruvate protects SHSY5Y cells against 6-hydroxydopamine-induced neurotoxicity by upregulating autophagy
    Luo, Yuening
    Sakamoto, Kazuichi
    PLOS ONE, 2023, 18 (02):
  • [47] Gelatin nanoparticle-mediated intranasal delivery of substance P protects against 6-hydroxydopamine-induced apoptosis: an in vitro and in vivo study
    Lu, Cui-Tao
    Jin, Rong-Rong
    Jiang, Yi-Na
    Lin, Qian
    Yu, Wen-Ze
    Mao, Kai-Li
    Tian, Fu-Rong
    Zhao, Ya-Ping
    Zhao, Ying-Zheng
    DRUG DESIGN DEVELOPMENT AND THERAPY, 2015, 9 : 1955 - 1962
  • [48] Polysaccharide from Amauroderma rugosum ameliorates 6-hydroxydopamine-induced neurotoxicity in SH-SY5Y cell model of Parkinson's disease
    Rangsinth, Panthakarn
    Pattarachotanant, Nattaporn
    Tencomnao, Tewin
    Cheung, Timothy Man-Yau
    Leung, George Pak-Heng
    BRITISH JOURNAL OF PHARMACOLOGY, 2023, 180 : 890 - 890
  • [49] 6-Hydroxydopamine-Induced Neurotoxicity in Rat Model of Parkinson's Disease: Is Reversed via Anti-Oxidative Activities of Curcumin and Aerobic Exercise Therapy
    Sokouti, Hadis
    Mohajeri, Daryoush
    Nourazar, Mir Alireza
    PHYSIOLOGICAL RESEARCH, 2022, 71 (04) : 551 - 560
  • [50] Alterations of Colonic Neuromuscular Excitatory Cholinergic Pathway in a Rat Model of 6-Hydroxydopamine-Induced Parkinson's Disease
    Pellegrini, Carolina
    Pellegrini, Carolina
    Fornai, Matteo
    Antonioli, Luca
    Colucci, Rocchina
    Sacco, Deborah
    Ippolito, Chiara
    Segnani, Cristina
    Levandis, Giovanna
    Cerri, Silvia
    Blandini, Fabio
    Bernardini, Nunzia
    Blandizzi, Corrado
    GASTROENTEROLOGY, 2014, 146 (05) : S363 - S363